TNYA (Tenaya Therapeutics) FCF Margin %: -8,553.33% (As of Mar. 2026)


TNYA Tenaya Therapeutics Inc TNYA
32 GF Score
Price $0.73
! 4 Warning Signs
View Full Analysis

What is Tenaya Therapeutics FCF Margin %?

Tenaya Therapeutics TNYA +2.13% 32 FCF Margin % is -8,553.33% as of Mar. 2026. GuruFocus rates TNYA with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 957 Biotechnology companies, Tenaya Therapeutics ranks worse than 96.55% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tenaya Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-19.25 Mil. Tenaya Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.23 Mil. Therefore, Tenaya Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was -8,553.33%.

As of today, Tenaya Therapeutics's current FCF Yield % is -40.53%.

The historical rank and industry rank for Tenaya Therapeutics's FCF Margin % or its related term are showing as below:

TNYA' s FCF Margin % Range Over the Past 10 Years
Min: -28725.33   Med: 0   Max: 0
Current: -28725.33

TNYA's FCF Margin % is ranked worse than
96.55% of 957 companies
in the Biotechnology industry
Industry Median: -84.65 vs TNYA: -28725.33

Tenaya Therapeutics FCF Margin % Related Terms

Tenaya Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Tenaya Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenaya Therapeutics FCF Margin % Chart

Tenaya Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Tenaya Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -8,553.33

TNYA vs MIST, NRXP, TLSA: FCF Margin % Comparison

For the Biotechnology subindustry, Tenaya Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tenaya Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tenaya Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tenaya Therapeutics's FCF Margin % falls into.


TNYA
32GF Score
Tenaya Therapeutics Inc TNYA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenaya Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tenaya Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-68.882/0
= %

Tenaya Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-19.245/0.225
=-8,553.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -8,553.33% mean?
Tenaya Therapeutics (TNYA) has a FCF Margin % of -8,553.33% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tenaya Therapeutics and its competitors. According to the industry distribution chart, Tenaya Therapeutics ranks #924 out of 957 companies in the Biotechnology industry, placing it in the top 96.6%.
Is Tenaya Therapeutics' FCF Margin % too high?
Tenaya Therapeutics' current FCF Margin % is -8,553.33%. Based on the distribution chart, Tenaya Therapeutics ranks #924 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tenaya Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Tenaya Therapeutics' FCF Margin % compare to MIST and NRXP?
According to the Biotechnology industry distribution chart, Tenaya Therapeutics ranks #924 out of 957 companies for FCF Margin %. This places Tenaya Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Tenaya Therapeutics and its competitors. Tenaya Therapeutics's current FCF Margin % is -8,553.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenaya Therapeutics stock overvalued right now?
Tenaya Therapeutics (TNYA) has a current FCF Margin % of -8,553.33%. The current FCF Margin % is -8,553.33%. Tenaya Therapeutics' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Tenaya Therapeutics (TNYA), the current FCF Margin % is -8,553.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tenaya Therapeutics Business Description

Address 171 Oyster Point Boulevard, Suite 500, 5th Floor, South San Francisco, CA, USA, 94080
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
32GF Score

Get the complete analysis for TNYA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.73
Price